Explore more publications!
Health & Wellness Today New York
Submit Press Release

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 6, 2025

Thriving Creatively Co-Founders to Present 'The Performance of Well-Being in Design' at the 2025 AIGA Design Conference
October 6, 2025

Thriving Creatively Co-Founders to Present 'The Performance of Well-Being in Design' at the 2025 AIGA Design Conference

Indeterminate EIN Presswire
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
October 6, 2025

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

Indeterminate GlobeNewswire
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
October 6, 2025

Ryoncil® Revenues Increase 66% in Second Quarter Post Launch

Indeterminate GlobeNewswire
Unified Youth Debuts The Wonder Fund with First-of-Its-Kind National Investment in Youth Mental Health and Wellbeing
October 6, 2025

Unified Youth Debuts The Wonder Fund with First-of-Its-Kind National Investment in Youth Mental Health and Wellbeing

Indeterminate EIN Presswire
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
October 6, 2025

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Indeterminate GlobeNewswire
RouteGenie Announces New Integration with SafeRide Health to Enhance Broker-Provider Connectivity
October 6, 2025

RouteGenie Announces New Integration with SafeRide Health to Enhance Broker-Provider Connectivity

Indeterminate EIN Presswire
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 6, 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq

Indeterminate GlobeNewswire
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
October 6, 2025

DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

Indeterminate GlobeNewswire
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
October 6, 2025

Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant

Indeterminate GlobeNewswire
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
October 6, 2025

Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease

Indeterminate GlobeNewswire
Biomea Fusion Announces Proposed Public Offering of Securities
October 6, 2025

Biomea Fusion Announces Proposed Public Offering of Securities

Indeterminate GlobeNewswire
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
October 6, 2025

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease

Indeterminate GlobeNewswire
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
October 6, 2025

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Indeterminate GlobeNewswire
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
October 6, 2025

Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
October 6, 2025

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Indeterminate GlobeNewswire
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
October 6, 2025

Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

Indeterminate GlobeNewswire
Equillium Announces Leadership and Corporate Updates
October 6, 2025

Equillium Announces Leadership and Corporate Updates

Indeterminate GlobeNewswire
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
October 6, 2025

Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)

Indeterminate GlobeNewswire
At just 13, Zacky Muñoz’s Vision for Expanding Access to Epinephrine Systems Becomes California Law After 2½-Year Legislative Effort
October 6, 2025

At just 13, Zacky Muñoz’s Vision for Expanding Access to Epinephrine Systems Becomes California Law After 2½-Year Legislative Effort

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions